Persistent market archive

Market News

Finance, business, and economy headlines with related U.S. tickers, event materiality, publisher context, and links to the original source.

1,708 archived storiesUpdated continuouslyTicker matching where identifiable
GlobeNewswire·Nov 5, 202652 signal

ANI Pharmaceuticals Announces Offer to Acquire Egetis

ANI Pharmaceuticals has announced a recommended public offer to acquire Egetis Therapeutics AB for approximately $560 million. This acquisition aims to expand ANI's rare disease business, leveraging Egetis's lead asset, EMCITATE®, an approved treatment for MCT8 deficiency with an estimated peak sales potential of over $300 million. The deal is unanimously recommended by Egetis's Board and supported by shareholders controlling 42% of its shares.

Mergers And AcquisitionsLife SciencesEarningsANIP
Alpha Vantage
Kalkine Media·Nov 5, 202648 signal

USBC, Inc. Submits Transition 10-K Report for Q4 2025 Amid Fiscal Year Shift

USBC, Inc. has filed a Transition Report on Form 10-K for the quarter spanning October 1, 2025, to December 31, 2025, reflecting its fiscal year end adjustment from September 30 to December 31, effective fiscal year 2026. The report details the company's change to a calendar-year reporting structure to align with operational cycles and industry peers. It also highlights 388,144,429 outstanding shares, a non-affiliate market value of $14,110,017, and mentions its "tokenized cryptocurrency treasury strategy" and Bitcoin holdings.

EarningsFinanceBlockchainUSBC
Alpha Vantage
Billionaires.Africa·Nov 5, 202657 signal

Newmont CEO Natascha Viljoen disposes of $2.9m in shares

Newmont CEO Natascha Viljoen, a South African mining engineer, disposed of 25,780 shares in the company valued at approximately $2.9 million between late October and early November. The majority of these shares were withheld for tax purposes related to restricted stock units vesting, with a smaller portion sold under a pre-arranged trading plan. Despite the sales, Viljoen retains a substantial stake in Newmont, worth about $11 million.

EarningsFinancial MarketsEconomy FiscalNEM
Alpha Vantage
Yahoo! Finance Canada·Nov 5, 202669 signal

Tenet Healthcare Corporation (THC) Stock Forecasts

Argus has raised its price target for Tenet Healthcare Corporation (THC) to $293.00, citing the company's strong position in healthcare services. As of November 4, 2026, THC's current price is $292.25. Tenet Healthcare operates 47 acute and specialty hospitals and over 500 ambulatory surgery centers across the U.S., predominantly in the South.

EarningsLife SciencesFinancial MarketsTHCHUMHCAUHS
Alpha Vantage
Investing.com Nigeria·Nov 5, 202666 signal

Goldman Sachs raises Expedia stock price target on solid Q3 results

Goldman Sachs increased its price target for Expedia Group Inc. shares to $320 from $310, maintaining a Buy rating, following Expedia's strong third-quarter 2026 earnings. The company's core operating metrics, including gross bookings, revenue, and adjusted EBITDA, surpassed expectations, driven by solid execution in both consumer and business-to-business segments, with AI investments also highlighted as a long-term opportunity.

EarningsFinancial MarketsFinanceEXPEGS
Alpha Vantage
The Manila Times·Nov 5, 202657 signal

Defiance ETFs Announces Closure of ASTN, STSM, and RKLZ Funds

Defiance ETFs, in conjunction with Tidal Financial Group, announced the closure and liquidation of three exchange-traded funds: ASTN, STSM, and RKLZ. This decision is part of Defiance's ongoing review of its product lineup to align with evolving market needs. The final trading day for these funds will be November 16, 2026, with liquidation occurring on November 20, 2026, at which point shares will be automatically redeemed for cash at NAV.

Financial MarketsFinanceSTSMNDAQCBOE
Alpha Vantage
Economies.com·Nov 5, 202645 signal

NZDUSD is on Track to Shake Off Negative Pressure – Analysis –05-11-2026

The NZDUSD pair rose in its latest intraday trading, driven by positive signals emerging from the relative strength indicators, which led the price to surpass the resistance of the EMA50, as an important step toward eliminating the negative pressure surrounding it. The pair is now challenging the pivotal resistance level at 0.5650, amid the dominance of a short-term bullish corrective wave.

Finance
Economies.com·Nov 5, 202647 signal

USDCAD Prepares to Break Through a Pivotal Support Level – Analysis –05-11-2026

The USDCAD pair declined in its latest intraday trading after successfully easing its oversold conditions on the relative strength indicators, preparing to break below the pivotal support level at 1.3935, amid the dominance of a short-term bearish corrective trend. It also continues to face negative pressure as it trades below EMA50, which acts as dynamic resistance and increases the likelihood of further losses in the near term.

Finance
TradingView·Nov 5, 202645 signal

New Zealand Dollar Extends Gains

The New Zealand dollar edged up to $0.563 on Thursday, extending gains from the previous session as the US dollar weakened further following a decisive victory by Democrats in the US midterm elections.The result eased fears of a disputed election outcome but raised the prospect of political gridloc...

Finance